China Pharma Holdings, Inc.
CPHI
$0.3034
$0.01083.69%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 2.15M | 1.80M | 1.10M | 1.96M | 2.92M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.15M | 1.80M | 1.10M | 1.96M | 2.92M |
| Cost of Revenue | 2.23M | 2.04M | 1.24M | 1.78M | 2.88M |
| Gross Profit | -79.20K | -233.20K | -146.70K | 177.90K | 42.70K |
| SG&A Expenses | 957.80K | 434.60K | 285.90K | 552.40K | 1.18M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.33M | 2.52M | 1.55M | 2.36M | 4.09M |
| Operating Income | -1.18M | -713.50K | -456.30K | -397.50K | -1.17M |
| Income Before Tax | -1.23M | -777.60K | -593.00K | -476.00K | -1.26M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.23M | -777.60K | -593.00K | -476.00K | -1.26M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.23M | -777.60K | -593.00K | -476.00K | -1.26M |
| EBIT | -1.18M | -713.50K | -456.30K | -397.50K | -1.17M |
| EBITDA | -327.10K | -192.00K | 238.50K | 282.40K | -501.70K |
| EPS Basic | -0.17 | -0.29 | -0.30 | -0.29 | -0.98 |
| Normalized Basic EPS | -0.11 | -0.18 | -0.19 | -0.18 | -0.61 |
| EPS Diluted | -0.17 | -0.29 | -0.30 | -0.29 | -0.98 |
| Normalized Diluted EPS | -0.11 | -0.18 | -0.19 | -0.18 | -0.61 |
| Average Basic Shares Outstanding | 7.28M | 2.64M | 1.98M | 1.62M | 1.29M |
| Average Diluted Shares Outstanding | 7.28M | 2.64M | 1.98M | 1.62M | 1.29M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
